Flow cytometric method transfer: Recommendations for best practice

被引:12
|
作者
Cabanski, Maciej [1 ]
Oldaker, Teri [2 ]
Stewart, Jennifer J. [3 ]
Selliah, Nithianandan [4 ]
Eck, Steve [5 ]
Green, Cherie [6 ,7 ]
Litwin, Virginia [8 ]
Vitaliti, Alessandra [1 ]
机构
[1] Novartis Pharma AG, Novartis Inst Biomed Res, Basel, Switzerland
[2] Oldaker Consulting LLC, San Clemente, CA USA
[3] Flow Contract Site Lab, Bothell, WA USA
[4] Cerba Res, Lake Success, NY USA
[5] AstraZeneca, Integrated Bioanal Clin Pharmacol & Safety Sci, R&D, Gaithersburg, MD USA
[6] Genentech Inc, Dept Dev Sci, San Francisco, CA USA
[7] Roche Grp, San Francisco, CA USA
[8] Caprion Biosci, Montreal, PQ, Canada
关键词
design control; flow cytometry; method transfer; technology transfer; validation; ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; VALIDATION; STANDARDIZATION; GUIDELINES; ASSAYS;
D O I
10.1002/cyto.b.21971
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
As with many aspects of the validation and monitoring of flow cytometric methods, the method transfer processes and acceptance criteria described for other technologies are not fully applicable. This is due to the complexity of the highly configurable instrumentation, the complexity of cellular measurands, the lack of qualified reference materials for most assays, and limited specimen stability. There are multiple reasons for initiating a method transfer, multiple regulatory settings, and multiple context of use. All of these factors influence the specific requirements for the method transfer. This recommendation paper describes the considerations and best practices for the transfer of flow cytometric methods and provides individual case studies as examples. In addition, the manuscript emphasizes the importance of appropriately conducting a method transfer on data reliability.
引用
收藏
页码:52 / 62
页数:11
相关论文
共 50 条
  • [21] Nail Psoriasis Clinical Presentation and Best Practice Recommendations
    Edwards, Felicity
    de Berker, David
    [J]. DRUGS, 2009, 69 (17) : CP2 - 2361
  • [22] Best Practice Recommendations for Replicating Experiments in Public Administration
    Walker, Richard M.
    Brewer, Gene A.
    Lee, M. Jin
    Petrovsky, Nicolai
    van Witteloostuijn, Arjen
    [J]. JOURNAL OF PUBLIC ADMINISTRATION RESEARCH AND THEORY, 2019, 29 (04) : 609 - 626
  • [24] Recommendations for best practice in a stroke vision service.
    Rowe, F. J.
    Walker, M.
    Rockliffe, J.
    Pollock, A.
    Noonan, C. P.
    Howard, C.
    Hepworth, L.
    Glendinning, R.
    Currie, J.
    [J]. CEREBROVASCULAR DISEASES, 2014, 37 : 313 - 313
  • [25] Translating the MDS Flow Cytometric Score into Clinical Practice
    Heron, Michiel
    Dovern, Elisabeth
    Bakker-Jonges, Liesbeth E.
    Posthuma, Eduardus F. M.
    Brouwer, Rolf E.
    Smedts, Frank
    Batstra, Manou R.
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2015, 88 (03) : 207 - 209
  • [26] STANDARDIZATION OF FLOW CYTOMETRIC METHODS IN THE CLINICAL-PRACTICE
    ORFAO, A
    CIUDAD, J
    LOPEZ, A
    SANMIGUEL, JF
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 1993, 51 (3-5) : 346 - 346
  • [27] Best practice transfer for future competitiveness: a study of best practices
    Jarrar, YF
    Zairi, M
    [J]. TOTAL QUALITY MANAGEMENT, 2000, 11 (4-6): : S734 - S740
  • [28] International consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia
    Wilson, Wyndham H.
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2007, 72B : S2 - S2
  • [29] Guiding the Practice of Wound Debridement Using Best Practice Recommendations and Consensus Statements
    LeBlanc, Kimberly
    [J]. JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2023, 50 (04) : 339 - 340
  • [30] Best practice recommendations for the transfer of cell-based assays for the measurement of neutralizing anti-drug antibodies
    Belouski, Shelley S.
    Born, Danika
    Jacques, Susan
    Harder, Brandon
    Reynhardt, Kai
    Kaliyaperumal, Arunan
    Gupta, Shalini
    [J]. BIOANALYSIS, 2016, 8 (17) : 1845 - 1857